Fundraising Fox
Exeliom Biosciences
Paris, FR · Founded 2016 · 10 employees on LinkedIn · 9 known investors
Find your way into Exeliom Biosciences
Sign up to find every way you can get introduced to Exeliom Biosciences
- Your email: who you already know at Exeliom Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Exeliom Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.
Founders & leadership
Exeliom Biosciences was founded in 2016 by Harry Sokol.
Investors · 9
How we know: the company's own site · Not right? Tell us
How we know: Forepont Capital Partners's portfolio page · funding news · startupmafia.eu · the VCSheet dataset · Not right? Tell us
How we know: funding news · microbiometimes.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AOct 2025 · 2 sources
Biocodex (lead), Crescent Ventures, Forepont Capital Partners, UI Investissement
Source ↗ - Undisclosed amountSeries A extensionJul 2023 · 2 sources
CE-Ventures (lead), Auriga Partners, Biocodex, Capital Grand Est, UI Investissement
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Exeliom Biosciences do?
- Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.
- Who founded Exeliom Biosciences?
- Exeliom Biosciences was founded by Harry Sokol in 2016.
- Who are Exeliom Biosciences's investors?
- Exeliom Biosciences's investors include Bpifrance, Agoranov, Forepont Capital Partners, Auriga Partners, UI Investissement.
- Where is Exeliom Biosciences headquartered?
- Exeliom Biosciences is headquartered in Paris, FR.